Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Assurex Health Inc.

www.assurerxhealth.com

Latest From Assurex Health Inc.

Myriad's GeneSight Psychotropic Genetic Test Improves Depression Therapy In Trial

Results of a randomized trial presented at the American Psychiatric Association conference show the GeneSight Psychotropic genetic test can improve the treatment of depression by identifying the medications most and least likely to be effective.

Personalized Medicine In Vitro Diagnostics

Device/Diagnostics Quarterly Deal Statistics, Q3 2016

Q3 medtech financing doubled in dollar volume to $3 billion, with debt offerings again representing the majority of the aggregate; acquisitions totaled $5.3 billion, mainly due to Johnson & Johnson’s $4.3 billion buy of Abbott Medical Optics. Diagnostics financings, which brought in $85 million, continued to decline, but at $5 billion, acquisitions showed a slight increase over the previous quarter, with Danaher’s takeover of Cepheid accounting for most of the M&A volume.

Market Intelligence Deals

Deals Shaping the Medical Industry, September 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2016.

Deals BioPharmaceutical

August M&A Analysis: Slow Month Highlighted By Unique Technologies

The dog-days of summer produced just a handful of mergers and acquisitions in the medtech sector and no blockbuster deals. However, several companies made smaller deals for innovative products in a range of sectors including IVDs, cardiovascular devices, and ophthalmology.

Commercial Companies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • AssureRx Health Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Assurex Health Inc.
  • Senior Management
  • Virginia C Drosos, Pres. & CEO
    Donato L Peter , SVP & CFO
    Mark S Verratti, SVP, Chief Sales & Business Dev. Officer
    Bryan M Dechairo, PhD, SVP, Med. Affairs & Clin. Dev.
    Donald R Wright, EVP & COO
    Jeff P Borcherding, VP, Mktg.
    Scott M Roth, VP, Product Dev.
  • Contact Info
  • Assurex Health Inc.
    Phone: (888) 987-9913
    6030 S. Mason-Montgomery Rd.
    Mason, OH 45040
    USA
UsernamePublicRestriction

Register